| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Rachit Jain | CFO;EVP | 2026-07-16 | 875 | $15.60 | $13.65kSell |
| Ramy Farid | President CEO | 2026-04-17 | 74,527 | $3.07 | $228.80kBuy |
| Ramy Farid | President CEO | 2026-04-17 | 43,000 | $3.07 | $132.01kBuy |
| Ramy Farid | President CEO | 2026-04-17 | 43,000 | $12.21 | $524.94kSell |
| Ramy Farid | President CEO | 2026-04-16 | 43,000 | $12.33 | $530.23kSell |
| Ramy Farid | President CEO | 2026-04-16 | 43,000 | $3.07 | $132.01kBuy |
| Rachit Jain | EVP CFO | 2026-04-16 | 844 | $12.75 | $10.76kSell |
| Jenny Herman | CAO | 2026-03-06 | 608 | $12.84 | $7.81kSell |
| Yvonne Tran | EVP CLO CPO | 2026-03-05 | 1,094 | $12.90 | $14.11kSell |
| Karen Akinsanya | President Head of Therapeutics RD and Chief Strategy Officer Partnerships | 2026-03-05 | 1,366 | $12.90 | $17.63kSell |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Melinda Gates Foundation Trust Bill | 9.33% | 6,981,664 | $132.79M | Insider |
| David E. Shaw | 8.28% | 6,196,609 | $117.86M | Insider |
| James E. Flynn | 2.13% | 1,596,167 | $30.36M | Insider |
| Richard Friesner | 1.89% | 1,413,618 | $26.89M | Insider |
| Ramy Farid | 0.54% | 405,351 | $7.71M | Insider |
| Cony Dcruz | 0.20% | 147,082 | $2.80M | Insider |
| Jorg Weiser | 0.18% | 134,442 | $2.56M | Insider |
| Kenneth Patrick Lorton | 0.12% | 89,241 | $1.70M | Insider |
| Karen Akinsanya | 0.09% | 69,956 | $1.33M | Insider |
| Robert Lorne Abel | 0.07% | 55,897 | $1.06M | Insider |